ÂÜÀòÂÒÂ×

Linda Shi currently serves as the Chief Medical Officer at GrandPharma (China) Co. Ltd, a position held since January 2021. Previously, Linda Shi worked at Janssen Research & Development, Johnson & Johnson, where roles included EU Regulatory Leader for GRA Neuroscience from August 2010 to August 2020, and Scientist in Drug Discovery and Early Development from August 2007 to July 2010. Linda Shi has substantial clinical research experience, having served as a Physician/Researcher in the Department of Anesthesiology at UZ Brussel from February 1996 to July 2007, overseeing Phase II-III clinical trials of COX-2 inhibitors and leading two research grants from the Belgian Society of Anesthesiology. Additional experience includes a brief tenure as a Visiting Researcher at Harvard Medical School in early 2007 and working as a Physician in Anesthesiology and Intensive Care at Wuhan General Hospital from September 1990 to February 1996. Linda Shi earned a Ph.D. in Medicine from Vrije Universiteit Brussel between 1998 and 2005.